Search results
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 5 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 5 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
Moderna says its combination COVID and flu vaccine tested better than separate shots
CBS News· 5 days agoModerna announced Monday that its combination COVID and flu vaccine showed positive results in a...
No, study didn't blame COVID-19 vaccines for excess pandemic deaths | Fact check
USA Today· 4 days agoA June 5 Facebook post (direct link, archive link) claims a new study has revealed alarming news...
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit...
The Conversation· 1 day agoEarlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. Combination vaccines
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 5 days agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
Fox News misinterprets results of study to blame millions of “excess deaths” on the COVID-19 vaccine
Media Matters· 2 days agoWritten by Helena Hind Published 06/13/24 9:21 AM EDT
Moderna’s COVID, flu combination vaccine shows stronger immune response, company announces
WHIO-TV 7 Dayton· 5 days agoModerna is working on a single vaccine that it says will protect people against both COVID-19 and...
Feeling rough after your COVID shot? That's a sign it's working
Medical Xpress· 5 days agoOne of the most common reasons for bypassing the COVID vaccine is concern about side effects like tiredness, muscle and joint pain, chills ...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 7 days agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...